Gentag believes that wearable biosensors linked with NFC devices have the power to transform medical and consumer diagnostics. We first patented the concept of an electronic “second skin” over a decade ago.
From the National Labs to Hospitals and Homes
Radar Responsive Tags, a sophisticated geolocation and tracking technology, are capable of precision locating items or individuals over large areas. First developed at the US National Laboratories for the Department of Defense, these tiny wireless chips, combined with sensors, are capable of providing exquisite location services.
This is a text block. Click the edit button to change this text.
Working to reduce costly hospital readmissions
By linking patients, wearable biological sensors that can be read with an encrypted NFC device, and doctors or hospitals, Gentag is working to reduce costly hospital readmissions, simplify patient discharge, and enable easy in-home self-monitoring.
Gentag, Mayo Clinic, NovioSense and Fraunhofer Join Forces to Lower the Cost of Diabetes Care GloballyJuly 14, 2015Read more
WASHINGTON, ROCHESTER, Minn., NIJMEGEN, Netherlands and DUISBURG, Germany, July 14, 2015 /PRNewswire/ — Exciting, new, patented technology platform poised to disrupt diabetes care delivery globally Extremely low-cost, pain-free system could be a game changer No more lancets, glucometers Real-time cloud-based readings deliverable to caregivers and providers anywhere instantly via NFC cell phones Opportunity to improve diabetes outcomes worldwide Building on the long-standing collaboration between Gentag and Mayo Clinic, and the long-standing collaboration between NovioSense and Fraunhofer Institute for Microelectronic Circuits and Systems (IMS), Gentag and NovioSense today announced that they have formed a joint venture to combat the epidemic of type 2 diabetes that is...
Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and DiabetesMarch 4, 2015Read more
ROCHESTER, Minn. — Mayo Clinic and Gentag, Inc. have reached an agreement to develop the next generation of wearable biosensors designed to fight obesity and diabetes. “We are hoping that this technology will be game-changer. These patch biosensors may help us reduce global obesity and diabetes,” says James Levine, M.D., Ph.D., a Mayo Clinic endocrinologist and obesity researcher. “They are accurate, inexpensive, and can be integrated into the care people receive.” A first-of-its-kind, the wearable patch sensors are the size of a small bandage, and are designed to be painless, wireless and disposable. In the bandage is a sensor that communicates via a closed-loop diabetes...
- October 28, 2014Read more
Skaneateles, NY, and Washington, DC, October 28, 2014 — Welch Allyn, a leading medical diagnostic device company that delivers pragmatic innovation at the point of care, and Gentag, Inc., a pioneer in disposable biosensors that can be read with near field communication (NFC) devices, announced today that they have entered into a strategic development agreement. Under the terms of the agreement, Welch Allyn and Gentag will bring to market near field communication technology for medical devices and sensors. The partnership with Gentag enables Welch Allyn to continue providing innovative solutions in medical settings, and NFC will allow the extension...